Schedule 13D ownership disclosure
Forma Therapeutics Holdings, Inc.,
Security class unavailable · CUSIP: 34633R104
Event date: 2020-06-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,011,651
- Percent of class
- 23.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-076904
- Form type
- SC 13D
- Filer
- Forma Therapeutics Holdings, Inc.
- CIK
- CIK 1538927
- Filed
- Jun 25, 2020
- Reporting period
- Jun 23, 2020
- Description
- Schedule 13D beneficial ownership